DDI Participates in the 26th Tetrahedron Symposium

We are proud of the participation of Dasman Diabetes Institute researchers at the 26th Tetrahedron Symposium which was held in China, one of the world’s leading conferences in medicinal chemistry and drug discovery.

During the symposium, our researchers presented two studies focused on innovative approaches for diabetes, obesity, and metabolic disease treatments, leveraging artificial intelligence to accelerate and enhance drug discovery.

This participation reflects the Institute’s commitment to advancing scientific research and strengthening its presence on the international stage, transforming research findings into impactful healthcare solutions.